MP Mian Altaf Demands Curbs On Spurious Drugs In LS
Srinagar: National Conference (NC) Member of Parliament (MP) Mian Altaf Ahmad today expressed concern over the deficiencies in J&K healthcare system. He was speaking during the discussion on demand for grants…
DCA Telangana Advisory On Fake And Spurious Medicines Of Minogain Products
HYDERABAD: The Drugs Control Administration, Telangana, has issued an advisory to the people of the Telangana state that an online portal www.minogain.in is offering various products which have been found…
Cipla To Commence Supplies To US From China Plant Later This Year
New Delhi: Drug major Cipla expects to commence supplies to the US market from its China facility in the second half of the current fiscal after getting approval from the…
Australian Mayne Pharma Sues Sun Pharma Over Patent Infringement
Canberra: Mayne Pharma has filed a lawsuit against Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said on Thursday.…
Indian National Charged With Selling Counterfeit Cancer Drugs
HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…
Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM
Jaipur: The Rajasthan government said on Tuesday that an ‘Anti-Narcotics Task Force’ would soon be formed to control the drug menace in the state. State Medical and Health Minister Gajendra Singh…
ICMR To Strengthen IPR Unit To Safeguard And Commercialize Scientific Innovations
Mumbai: In a strategic move to bolster its Intellectual Property Rights (IPR) capabilities, the Indian Council of Medical Research (ICMR) has issued an invitation for expressions of interest from its in-house…
Kanimozhi N.V.N. Somucalls For Action Against Firms Involved In Unethical Practices In Clinical Trials
Chennai: Member of Parliament (Rajya Sabha) Kanimozhi N.V.N. Somu urged the Union government to take stringent action on all those involved in unethical practices in clinical trials. Citing an issue raised…
India Paves Way For A Cheaper Anti-TB Drug For Kids
New Delhi: The Indian Patent Office’s rejection of Johnson & Johnson’s (J&J) application for the paediatric version of its anti-tuberculosis (TB) drug, bedaquiline, is likely to have broader implications for access…
Boehringer Ingelheim Offers Humira Biosimilar At 92% Discount
Washington: Boehringer Ingelheim will sell an unbranded version of AbbVie’s reference drug at a 92% discount to gain traction in the Humira (adalimumab) biosimilar market. Patients will be able to purchase…
